Article Text

Download PDFPDF
Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse
  1. Y van Eijk1,
  2. A Boonen2,
  3. G Schulpen1,
  4. V Schrijnemaekers1,
  5. H Fiolet1,
  6. S j van der Linden2
  1. 1Department of Integrated Care, University Hospital, Maastricht, The Netherlands
  2. 2Department of Internal Medicine, Division of Rheumatology, Caphri Research Institute, University Hospital Maastricht, The Netherlands
  1. Correspondence to:
    MsY van Eijk
    Department of Integrated Care, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands; yve{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

After introduction of reimbursement of the cost of infliximab for the treatment of patients with active rheumatoid arthritis (RA),1 several hospitals had insufficient capacity at their hospital’s day care centre to administer the drug. Therefore, we explored the possibility of administering infliximab in an extramural setting supervised by a rheumatology specialist nurse (RSN).

A vacant room in a nursing home 5 km from the hospital was prepared as the infusion facility. Two nurses and the nursing home physician were given details of the clinical aspects of RA, with emphasis on treatment with infliximab. The hospital infliximab protocol, including the screening before each infusion, the preparation and administration of infliximab, and the safety procedure, was adapted. A form to guarantee communication between the hospital and the extramural setting was developed. Arrangements with the hospital pharmacy were made to assure punctual delivery of the exact number …

View Full Text